| Literature DB >> 31720121 |
Abstract
BACKGROUND: Physiotherapy of carpal tunnel syndrome (CTS) involves manual therapy based on neurodynamic techniques. Until now, two randomized controlled trials have shown that immediately after therapy, CTS patients who received neurodynamic techniques had significant improvement in nerve conduction, pain, symptom severity (SSS), functional state (FSS), muscle strength (MS) and two-point discrimination (2PD). However, long-term effects seem to be more important, as they are the only ones that can significantly improve the patient's health and influence economic and social costs. Thus, the objective of this study was to evaluate the long-term (six months) effects of neurodynamic techniques in the conservative treatment of CTS patients.Entities:
Keywords: Carpal tunnel syndrome; Conservative treatment; Manual therapy; Median nerve; Neurodynamic technique; Physical therapy
Year: 2019 PMID: 31720121 PMCID: PMC6844241 DOI: 10.7717/peerj.8012
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flow diagram.
Basic characteristics of the examined population.
| Characteristics | Group A ( | Group B ( | ||||
|---|---|---|---|---|---|---|
| Baseline | 6 months later | Baseline | 6 months later | |||
| Women (%) | 40 (87) | 40 (87) | NA | 40 (87) | 40 (87) | NA |
| Age (SD) year | 54.6 (8.4) | 54.7 (8.3) | 0.93 | 54.1 (9.3) | 54.2 (9.3) | 0.93 |
| Body mass (SD) kg | 70.4 (11.1) | 70.5 (10.8) | 0.96 | 70.4 (11.1) | 70.5 (10.8) | 0.96 |
| Height (SD) cm | 163.4 (6.88) | 163.6 (6.86) | 0.89 | 163.5 (6.5) | 163.4 (6.6) | 0.98 |
| BMI (SD) kg/m2 | 26.6 (4.17) | 26.7 (4.12) | 0.90 | 26.6 (4.71) | 26.8 (4.57) | 0.92 |
|
| ||||||
| —Unilateral (%) | 34 (74) | 34 (74) | NA | 45 (74) | 45 (74) | NA |
| —Bilateral (%) | 12 (26) | 12 (26) | NA | 16 (26) | 16 (26) | NA |
Notes.
Data immediately after 10 weeks of treatment from published articles (Group A —Wolny & Linek (2019); Group B —Wolny & Linek (2018)).
‘t’-test for dependent variables.
number of participants
not applicable
carpal tunnel syndrome
body mass index
Outcomes measured in the examined population.
| Characteristics | Group A ( | Group B ( | ||||
|---|---|---|---|---|---|---|
| Baseline | 6 months later | Baseline | 6 months later | |||
| SCV (SD) m/s | 37.8 (10.9) | 36.1 (10.3) | 0.37 (2.19–5.73) | 36.5 (10.3) | 34.4 (10.7) | 0.22 (1.25–5.27) |
| MCV (SD m/s | 55.9 (7.21) | 53.8 (9.75) | 0.21 (1.11–5.25) | 55.7 (6.36) | 54.4 (5.29) | 0.15 (0.49–3.13) |
| MT (SD) t(ms) | 4.53 (0.67) | 4.45 (0.57) | 0.53 (0.15–0.31) | 4.46 (0.72) | 4.39 (0.63) | 0.52 (0.14–0.27) |
| NPRS (SD) (0–10) | 1.38 (1.04) | 1.04 (0.57) | 0.00 | 1.41 (1.04) | 1.07 (0.77) | 0.00 |
| BCTQ-SSS (SD) | 1.81 (0.46) | 1.73 (0.45) | 0.31 (0.08–0.25) | 1.71 (0.45) | 1.48 (0.35) | 0.00 |
| BCTQ-FSS (SD) | 2.02 (0.68) | 1.81 (0.55) | 0.06 (0.01–0.44) | 1.95 (0.61) | 1.82 (0.49) | 0.15 (0.04–0.31) |
| MS CG (SD) kg | 28.4 (6.32) | 29.5 (5.89) | 0.00 | 27.3 (6.22) | 28.1 (5.33) | 0.00 |
| MS PG (SD) kg | 7.92 (1.46) | 8.45 (1.61) | 0.00 | 7.88 (1.55) | 8.31 (1.34) | 0.00 |
| 2PD FI (SD) | NA | 4.04 (0.86) | 3.81 (0.69) | 0.14 (0.01–0.47) | ||
| 2PD FII (SD) | 3.43 (0.82) | 3.21 (0.75) | 0.07 (0.02–0.46) | |||
| 2PD FIII (SD) | 3.38 (0.88) | 3.45 (0.91) | 0.84 (0.84–0.69) | |||
Notes.
Data immediately after 10 weeks of treatment from published articles (Group A —Wolny & Linek (2019); Group B—Wolny & Linek (2018)).
‘t’- test for dependent variables.
statistically significant difference.
sensory conduction velocity
motor conduction velocity
motor latency
Numerical Pain Rating Scale
Boston Carpal Tunnel Questionnaire
Symptom Severity Scale
Functional Status Scale
Muscle Strength Cylindrical Grip
Muscle Strength Pincer Grip
Two–Point Discrimination Sense
Finger I, II, III
not applicable